Wellgistics terminates settlement with Silverback Capital; no further share issuance under Section 3(a)(10)

Wellgistics Health, Inc.

Company terminated Settlement Agreement with Silverback Capital Inc., effective April 3, 2026.
Previously issued 6,866,000 shares of common stock under Section 3(a)(10) pursuant to the settlement.
Termination ends all obligations; no additional shares will be issued and Silverback must return claims to creditors.
Company pursuing alternative strategic and financing initiatives; termination eliminates future dilution.

item 1.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Wellgistics Health, Inc. terminated Settlement Agreement with Silverback Capital Inc. (effective 2026-04-03).

Action: termination
Agreement: settlement
Counterparty: Silverback Capital Inc.
Effective: 2026-04-03

Exact text from the filing

On April 3, 2026, Wellgistics Health, Inc. (the “Company”) delivered written notice to Silverback Capital Inc. terminating that certain Settlement Agreement and Stipulation, dated January 28, 2026 (the “Settlement Agreement”), previously entered into between the Company and Silverback Capital Inc.

View on SEC.gov

84 material agreements filed in the last 30 days. Browse all material agreements →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-015898

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.